Trial Profile
Comparison of Sugammadex Versus Neostigmine in Women at High Risk of Postoperative Nausea and Vomiting After Laparoscopic Gynaecological Surgery: A Randomized Controlled Trial
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Jul 2018
Price :
$35
*
At a glance
- Drugs Sugammadex (Primary) ; Neostigmine
- Indications Neuromuscular blockade; Postoperative nausea and vomiting
- Focus Adverse reactions
- 27 Jun 2018 Status changed from recruiting to completed.
- 16 Feb 2016 New trial record